Mono Pharmacare (NSE:MONOPHARMA) FCF Margin %: 2.49% (As of Sep. 2025)


NSE:MONOPHARMA Mono Pharmacare Ltd NSE:MONOPHARMA
9 GF Score
Price ₹11.00
! 6 Warning Signs
View Full Analysis

What is Mono Pharmacare FCF Margin %?

Mono Pharmacare NSE:MONOPHARMA -1.79% 9 FCF Margin % is 2.49% as of Sep. 2025. GuruFocus rates NSE:MONOPHARMA with a GF Score™ of 9/100. The stock has 6 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Mono Pharmacare ranks worse than 58.2% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Mono Pharmacare's Free Cash Flow for the six months ended in Sep. 2025 was ₹16 Mil. Mono Pharmacare's Revenue for the six months ended in Sep. 2025 was ₹663 Mil. Therefore, Mono Pharmacare's FCF Margin % for the quarter that ended in Sep. 2025 was 2.49%.

As of today, Mono Pharmacare's current FCF Yield % is 3.01%.

The historical rank and industry rank for Mono Pharmacare's FCF Margin % or its related term are showing as below:

NSE:MONOPHARMA' s FCF Margin % Range Over the Past 10 Years
Min: -48.94   Med: -3   Max: 0.61
Current: 0.4

During the past 5 years, the highest FCF Margin % of Mono Pharmacare was 0.61%. The lowest was -48.94%. And the median was -3.00%.

NSE:MONOPHARMA's FCF Margin % is ranked worse than
58.2% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 3.1 vs NSE:MONOPHARMA: 0.40

Mono Pharmacare FCF Margin % Related Terms

Mono Pharmacare FCF Margin % Historical Data

* Premium members only.

The historical data trend for Mono Pharmacare's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mono Pharmacare FCF Margin % Chart

Mono Pharmacare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
FCF Margin %
-3.00 0.61 -48.94 -7.31 -2.69

Mono Pharmacare Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
FCF Margin % Get a 7-Day Free Trial Premium Member Only -13.27 -0.21 -3.98 -1.31 2.49

Mono Pharmacare FCF Margin % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Mono Pharmacare's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mono Pharmacare FCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Mono Pharmacare's FCF Margin % falls into.


NSE:MONOPHARMA
9GF Score
Mono Pharmacare Ltd NSE:MONOPHARMA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mono Pharmacare FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Mono Pharmacare's FCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-45.291/1683.449
=-2.69 %

Mono Pharmacare's FCF Margin for the quarter that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=16.487/662.912
=2.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 2.49% mean?
Mono Pharmacare (NSE:MONOPHARMA) has a FCF Margin % of 2.49% as of Sep. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mono Pharmacare and its competitors. According to the industry distribution chart, Mono Pharmacare ranks #387 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 58.2%.
Is Mono Pharmacare's FCF Margin % too high?
Mono Pharmacare's current FCF Margin % is 2.49%. The Healthcare Providers & Services industry median FCF Margin % is 3.10. Mono Pharmacare's value of 2.49% is 19.7% below this industry median. Based on the distribution chart, Mono Pharmacare ranks #387 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mono Pharmacare has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Mono Pharmacare's FCF Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Mono Pharmacare ranks #387 out of 665 companies for FCF Margin %. This places Mono Pharmacare in the lower half of its industry. The industry median FCF Margin % is 3.10. Mono Pharmacare's value of 2.49% is 19.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.10, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mono Pharmacare's current FCF Margin % of 2.49% is 19.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mono Pharmacare and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mono Pharmacare's current FCF Margin % is 2.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mono Pharmacare stock overvalued right now?
Mono Pharmacare (NSE:MONOPHARMA) has a current FCF Margin % of 2.49%. The current FCF Margin % is 2.49% and 19.7% below the Healthcare Providers & Services industry median of 3.10. Mono Pharmacare's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Mono Pharmacare (NSE:MONOPHARMA), the current FCF Margin % is 2.49% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mono Pharmacare Business Description

Address 1A, Krinkal Apartment, Opposite Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007
Mono Pharmacare Ltd distributes a broad range of pharmaceutical products across India. Its portfolio includes antibiotics, antifungal medicines, cough and cold remedies, antacids, analgesics, nutraceuticals, skincare, antiseptics, cardiac and diabetic drugs, and cosmetic items. The company operates through contract manufacturing, sourcing products from various manufacturers and supplying them to healthcare providers and pharmacies. Revenue is generated through the sales and distribution of these pharmaceutical and healthcare products in the Indian market.
9GF Score

Get the complete analysis for NSE:MONOPHARMA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹11.00
Price